PGCL/Poly(caprolactone-co-glycolide)
Polyglycolic acid-polycaprolactone copolymer (PGCL) is a novel medical material.
Firstly, PGCL exhibits excellent biocompatibility in medicine. Biocompatibility refers to the compatibility between a material and human tissues, including cellular compatibility, tissue compatibility, and systemic compatibility. PGCL has attracted significant attention due to its low toxicity, non-sensitizing properties, and good tissue compatibility. It can be gradually degraded and metabolized by human tissues, reducing irritation and damage to the body, thereby lowering the risks of medical procedures.
Secondly, PGCL also possesses excellent mechanical properties and plasticity. It has high strength and wear resistance, allowing it to withstand certain pressures and tensions in various medical environments. Furthermore, the shape and properties of PGCL can be modified by adjusting the formulation and process parameters to better adapt to different clinical needs. This provides more options for the medical field and contributes to the development of more efficient and safer medical devices.
Furthermore, PGCL also exhibits good sustained-release properties. Drug sustained release is the process of controlling the rate of drug release over a specific time. PGCLs can modulate drug release rates by altering their structure and composition to achieve stable plasma drug concentrations and long-lasting therapeutic effects.
